Steven G. Waguespack | Authors


EP. 2A: The Effect of Larotrectinib on the Treatment Landscape for NTRK Fusion-positive Cancers

January 27, 2022

In this first video of the series, Steven G. Waguespack, MD, of the University of Texas MD Anderson Cancer Center provides an overview of the safety and efficacy of larotrectinib and considers how it has impacted the treatment landscape for NTRK fusion-positive cancers.